Eventide Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $60.1M | Sell |
|
|||||
|
2023
Q3 | $57.5M | Sell |
|
|||||
|
2023
Q2 | $73.7M | Buy |
|
|||||
|
2023
Q1 | $61.7M | Sell |
|
|||||
|
2022
Q4 | $102M | Hold |
|
|||||
|
2022
Q3 | $117M | Sell |
|
|||||
|
2022
Q2 | $78.4M | Sell |
|
|||||
|
2022
Q1 | $94.8M | Hold |
|
|||||
|
2021
Q4 | $98M | Hold |
|
|||||
|
2021
Q3 | $91.5M | Hold |
|
|||||
|
2021
Q2 | $85.3M | Sell |
|
|||||
|
2021
Q1 | $117M | Buy |
|
|||||
|
2020
Q4 | $91.5M | Hold |
|
|||||
|
2020
Q3 | $69.7M | Hold |
|
|||||
|
2020
Q2 | $100M | Hold |
|
|||||
|
2020
Q1 | $64.9M | Buy |
|
|||||
|
2019
Q4 | $16.2M | Sell |
|
|||||
|
2019
Q3 | $4.83M | Sell |
|
|||||
|
2019
Q2 | $22.1M | Buy |
|